人乳头瘤病毒疫苗更新临床指南：韩国妇科肿瘤学会指南。
Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines.
机构信息
Department of Obstetrics and Gynecology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
出版信息
J Gynecol Oncol. 2021 Nov;32(6):e94. doi: 10.3802/jgo.2021.32.e94.
Abstract
Since the human papillomavirus (HPV) vaccine guidelines were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2011, 2016, and 2019, several recent studies on the efficacy and safety of HPV vaccines in middle-aged women and men have been reported. Furthermore, there has been an ongoing debate regarding the efficacy of the HPV vaccine in women with prior HPV infection or who have undergone conization for cervical intraepithelial neoplasia (CIN). We searched and reviewed studies on the efficacy and safety of the HPV vaccine in middle-aged women and men and the efficacy of the HPV vaccine in patients infected with HPV and those who underwent conization for CIN. The KSGO updated their guidelines based on the results of the studies included in this review.
摘要
自 2011 年、2016 年和 2019 年韩国妇科肿瘤学会 (KSGO) 制定人乳头瘤病毒 (HPV) 疫苗指南以来，已经有几项关于 HPV 疫苗在中年女性和男性中的疗效和安全性的最新研究报告。此外，对于 HPV 疫苗在既往 HPV 感染或因宫颈上皮内瘤变 (CIN) 而行锥切术的女性中的疗效一直存在争议。我们搜索并回顾了 HPV 疫苗在中年女性和男性中的疗效和安全性以及 HPV 疫苗在 HPV 感染患者和 CIN 锥切术后患者中的疗效的研究。KSGO 根据本综述中包含的研究结果更新了他们的指南。
相似文献
1
Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines.人乳头瘤病毒疫苗更新临床指南：韩国妇科肿瘤学会指南。
J Gynecol Oncol. 2021 Nov;32(6):e94. doi: 10.3802/jgo.2021.32.e94.
2
Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline.《九价人乳头瘤病毒疫苗临床应用指南：韩国妇科肿瘤学会指南》
J Gynecol Oncol. 2019 Mar;30(2):e31. doi: 10.3802/jgo.2019.30.e31. Epub 2019 Jan 9.
3
Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline.宫颈癌预防性疫苗接种：韩国妇科肿瘤学会指南
J Gynecol Oncol. 2016 May;27(3):e30. doi: 10.3802/jgo.2016.27.e30.
4
Candidate HPV genotypes not included in the 9-valent vaccine for prevention of CIN 2-3.未包含在九价 HPV 疫苗中的候选 HPV 基因型与预防 CIN2-3 相关。
Int J Gynecol Cancer. 2020 Jul;30(7):954-958. doi: 10.1136/ijgc-2019-001069. Epub 2020 May 28.
5
The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study.人乳头瘤病毒类型对接受 HPV 疫苗补种计划中 HPV 免疫接种女性阴道镜检查性能的影响：一项两中心观察性研究。
BJOG. 2017 Aug;124(9):1394-1401. doi: 10.1111/1471-0528.14563. Epub 2017 Mar 9.
6
Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance.中国东南部浙江省浸润性宫颈癌和宫颈上皮内瘤变中HPV基因型分布：建立监测基线
Int J Environ Res Public Health. 2015 Sep 2;12(9):10794-805. doi: 10.3390/ijerph120910794.
7
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.二价L1病毒样颗粒疫苗针对16型和18型人乳头瘤病毒长达4.5年的持续疗效：一项随机对照试验的随访结果
Lancet. 2006 Apr 15;367(9518):1247-55. doi: 10.1016/S0140-6736(06)68439-0.
8
Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.人乳头瘤病毒（HPV）16和18型疫苗接种对切除治疗后现患感染及宫颈病变发生率的影响。
Am J Obstet Gynecol. 2016 Aug;215(2):212.e1-212.e15. doi: 10.1016/j.ajog.2016.02.021. Epub 2016 Feb 16.
9
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of .人乳头瘤病毒疫苗针对最严格的宫颈肿瘤终点（基于登记处的随访）的十年随访
BMJ Open. 2017 Aug 18;7(8):e015867. doi: 10.1136/bmjopen-2017-015867.
10
Declining rates of cervical intraepithelial neoplasia in British Columbia, Canada: An ecological analysis on the effects of the school-based human papillomavirus vaccination program.加拿大卑诗省宫颈上皮内瘤变发病率的下降：基于学校的人乳头瘤病毒疫苗接种计划效果的生态学分析。
Int J Cancer. 2021 Jul 1;149(1):191-199. doi: 10.1002/ijc.33513. Epub 2021 Feb 26.
引用本文的文献
1
Effectiveness of the Human Papillomavirus Vaccine in Extended Age Groups: A Real-World Analysis Based on the Korean HPV Cohort Study.人乳头瘤病毒疫苗在扩大年龄组中的有效性：基于韩国人乳头瘤病毒队列研究的真实世界分析
Cancers (Basel). 2025 Aug 3;17(15):2561. doi: 10.3390/cancers17152561.
2
Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines.临床宫颈癌实践指南：韩国妇科肿瘤学会指南。
J Gynecol Oncol. 2024 Mar;35(2):e44. doi: 10.3802/jgo.2024.35.e44. Epub 2024 Feb 13.
本文引用的文献
1
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study.27-45 岁女性与 16-26 岁女性相比，九价人乳头瘤病毒疫苗的免疫原性和安全性：一项开放性 3 期研究。
Vaccine. 2021 May 12;39(20):2800-2809. doi: 10.1016/j.vaccine.2021.01.074. Epub 2021 Mar 3.
2
Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.人乳头瘤病毒疫苗接种与韩国少女严重不良事件的相关性：全国队列研究。
BMJ. 2021 Jan 29;372:m4931. doi: 10.1136/bmj.m4931.
3
Prophylactic HPV vaccination after conization: A systematic review and meta-analysis.宫颈锥切术后预防性 HPV 疫苗接种：系统评价和荟萃分析。
Vaccine. 2020 Sep 22;38(41):6402-6409. doi: 10.1016/j.vaccine.2020.07.055. Epub 2020 Aug 4.
4
HPV Vaccination as Adjuvant to Conization in Women with Cervical Intraepithelial Neoplasia: A Study under Real-Life Conditions.人乳头瘤病毒疫苗作为宫颈上皮内瘤变女性锥切术的辅助治疗：一项真实生活条件下的研究
Vaccines (Basel). 2020 May 23;8(2):245. doi: 10.3390/vaccines8020245.
5
Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women: A Systematic Review and Meta-analysis.辅助型人乳头瘤病毒疫苗在未接种疫苗女性中减少复发性宫颈发育不良：系统评价和荟萃分析。
Obstet Gynecol. 2020 May;135(5):1070-1083. doi: 10.1097/AOG.0000000000003833.
6
Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis.预防性人乳头瘤病毒疫苗接种以预防宫颈上皮内瘤变复发：一项荟萃分析。
Int J Gynecol Cancer. 2020 Jun;30(6):777-782. doi: 10.1136/ijgc-2020-001197. Epub 2020 Apr 9.
7
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial.预防性四价 HPV 疫苗可否用于 CIN 妇女的治疗？一项随机试验。
BMC Public Health. 2020 Feb 27;20(1):274. doi: 10.1186/s12889-020-8371-z.
8
Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution's Experience.人乳头瘤病毒疫苗对接受宫颈发育异常利普刀手术女性的疗效：单机构经验
Vaccines (Basel). 2020 Jan 25;8(1):45. doi: 10.3390/vaccines8010045.
9
Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine.人乳头瘤病毒四价疫苗接种的性行为活跃女性青少年的口腔人乳头瘤病毒感染风险。
JAMA Netw Open. 2019 Oct 2;2(10):e1914031. doi: 10.1001/jamanetworkopen.2019.14031.
10
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.人乳头瘤病毒疫苗接种：免疫实践咨询委员会的最新建议。
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702. doi: 10.15585/mmwr.mm6832a3.
Zotero 插件